RBF Capital’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

RBF Capital’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150,000	Closed	-$272K	–	558
2023 Q2	$272K	Buy	+150,000	New	+$274K	0.02%	440

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RBF Capital's PRDS Position: Q3 2023 in Review

RBF Capital sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 150,000 shares — an estimated $272K sold.

RBF Capital first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $272K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

RBF Capital reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
RBF Capital sold 150,000 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $272K.
RBF Capital first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
RBF Capital's Pardes Biosciences, Inc. Common Stock position peaked at $272K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on RBF Capital's 13F filing for Q3 2023, filed 14 Nov 2023.